Language
English
German
^M
Dutch
Spanish
Title:
Which way for genetic-test regulation? Assign regulation appropriate to the level of risk
Source:
Nature [0028-0836] Javitt, G yr:2010
Basic
Full text
Full text available via
Nature
Year:
Volume:
Issue:
Start Page:
Document delivery
Request document via
Library/Bibliothek
Users interested in this article also expressed an interest in the following:
description
1.
Lahn, Bruce T.
"Let's celebrate human genetic diversity."
Nature
461.7265 (2009): 726-728.
description
2.
Rieder, Travis N.
"In Opioid Withdrawal, With No Help In Sight."
Health Affairs
36.1 (2017): 182-185.
description
3.
Shah, R.
"Personalized medicine: is it a pharmacogenetic mirage?"
British journal of clinical pharmacology
74.4 (2012): 698-721.
description
4.
Cunningham, Julie L.
"Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program."
Pain medicine
17.9 (2016): 1676-1685.
description
5.
Cleary, Brian J.
"Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women."
Addiction
108.4 (2013): 762-770.
description
6.
Aggarwal, A.
"Persistent dystonia following opioid withdrawal."
Progress in neuro-psychopharmacology & biological psychiatry
35.2 (2011): 640-640.
description
7.
Knoppers, Bartha M.
"Sampling Populations of Humans Across the World: ELSI Issues."
Annual review of genomics and human genetics
13.1 (2012): 395-413.
description
8.
Meiser, B.
"Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing."
Oncology nursing forum
39.2 (2012): 11-11.
description
9.
Cohen, Joshua P.
"Overcoming regulatory and economic challenges facing pharmacogenomics."
New biotechnology
29.6 (2012): 751-6.
description
10.
Offit, K.
"Personalized medicine: new genomics, old lessons."
Human genetics
130.1: 1-14.
description
11.
Macpherson, C.
"Undertreating pain violates ethical principles."
Journal of Medical Ethics
35.10 (2009): 603-606.
description
12.
Price, R. G., G.
"DARWIN'S VIEWS ON RACE MATTER."
Free inquiry
29.2 (2009): 40-44.
description
13.
Li, B.
"Genetic structure of Hmong-Mien speaking populations in East Asia as revealed by mtDNA lineages."
Molecular Biology and Evolution
22.3 (2005): 725-34.
description
14.
Stanley, T H H.
"The history and development of the fentanyl series."
Journal of Pain and Symptom Management
7.3 (1992): 3-7.
description
15.
Gordon, M.
"Clyburn : Respecting Differences Can Lead to Successful Communities."
Nation's cities weekly
31.1 (2008): 7-7.
description
16.
Mastana, S.
"Molecular genetic variation in the East Midlands, England: analysis of VNTR, STR and Alu insertion/deletion polymorphisms."
Annals of human biology
30.5 (2003): 538-50.
description
17.
Dambrin, C.
"Pharmacodynamics of immunosuppressive drugs."
Current opinion in immunology
12.5 (2000): 557-62.
description
18.
Crow, JF.
"Human Genetic Diversity: Genetic Variation and Its Maintenance."
Science
236.4807 (1987): 1475-1476.
description
19.
Chan, Isaac S.
"Personalized Medicine: Progress and Promise."
Annual review of genomics and human genetics
12.1 (2010): 217-44.
description
20.
Suzuki, J.
"A review: Fentanyl and non-pharmaceutical fentanyls."
Drug and alcohol dependence
171 (2017): 107-116.
View More...
View Less...
Select All
Clear All
Save Citations
Select Format
RefWorks
EndNote
ProCite
Reference Manager
Submit citation export
Advanced
Author
Other articles by this author? -- in
GeoRef
author:
Javitt, G
last name
initials
Other articles by this author? -- in
Online Contents Geosciences
author:
Javitt, G
last name
initials
Other articles by this author? -- using
Web of Science
author:
Javitt, G
last name
initials
Web Search
Find related information in
a Web Search Engine
Excite
Google
HotBot
Ixquick
ZOO
Ask
Yahoo!
Bing
Naver
Search Terms:
Search for related information in
Google Scholar
Article Title
Author Name
Journal Title
Other Search
Search Terms:
A service provided by the
Library of the Wissenschaftspark Albert Einstein
, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.